Inventurus Knowledge Solutions (IKS) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
15 Apr, 2026Executive summary
Achieved fifth consecutive quarter of industry-leading performance since going public in December 2024, with strong execution across strategic pillars and robust revenue growth of 24% YoY in INR and 19% in USD for Q3 FY26.
Business model leverages AI and technology to decouple revenue growth from headcount, targeting a $260 billion TAM in U.S. healthcare chore tasks.
Integration and optimization of AQuity acquisition is nearly complete, driving margin expansion, cross-sell traction, and customer pruning.
Maintained deep client relationships, with 90%+ revenues from repeat customers and 450+ enterprise-level customers.
Recognized as Best in KLAS for Virtual Scribing Services and clinical documentation, and received the ET Edge Impactful CEO Award.
Financial highlights
Q3 FY26 revenue was INR 8,150 million, up 24% year-over-year; EBITDA was INR 2,816 million, up 40.4% year-over-year, with EBITDA margin at 35%.
PAT for Q3 FY26 was INR 1,833 million, up 41.4% year-over-year; Adjusted PAT was INR 2,154 million, up 48% year-over-year.
EPS for Q3 FY26 was 11.0, up 40.5% year-over-year; return on equity at 30% (29.8% reported).
Operating and free cash flow conversion from EBITDA and PAT close to 100%, with OCF and FCF for Q3 FY26 growing 84.8% and 79.9% year-over-year.
Annualized EBITDA per employee increased to INR 0.91 million from INR 0.64 million year-over-year.
Outlook and guidance
Continued focus on technology-led growth, with further R&D and SG&A investments expected to keep EBITDA margins in the low-to-mid 30s.
Revenue from new deals (Femwell, StrideCare, VitalMD, and two unnamed) to start contributing from Q4 FY26 and Q1-Q3 FY27.
Management expects most growth to come from existing customer expansion, with 85-90% of growth from this channel.
Strategic investments in technology and platform capabilities to drive future growth.
The company will continue to monitor regulatory changes, particularly regarding new labour codes.
Latest events from Inventurus Knowledge Solutions
- $557M deal creates an AI-powered healthcare platform with strong rural market presence.IKS
M&A announcement24 Apr 2026 - $557M TruBridge acquisition to drive integrated healthcare growth and FY27 accretion.IKS
Q4 25/2623 Apr 2026 - Q2 FY26 delivered strong growth, margin expansion, and strategic investment in healthcare tech.IKS
Q2 25/263 Feb 2026 - 16% revenue growth, 31% EBITDA margin, and major client wins marked Q3 FY25.IKS
Q3 24/259 Jan 2026 - Strong revenue and margin growth, major platform wins, and high cash generation in FY25.IKS
Q4 24/256 Jan 2026 - Q1 FY26 saw double-digit revenue and profit growth, margin expansion, and strong cash flow.IKS
Q1 25/266 Jan 2026